Genomic Instability: Clinical Trials

1 trial for Genomic Instability, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Genomic Instability: new trials by email Literature Review of Genomic Instability trials Research Report on Genomic Instability

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer
Avelumab - POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability
Phase 3TerminatedRoyal Marsden NHS Foundation Trust302018-08-312022-10-07

Narrower conditions

Colonic Neoplasms (1)  ·  Microsatellite Instability (1)

Broader conditions

Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

avelumab (1)

Sponsors

Royal Marsden NHS Foundation Trust (1)

Countries

United Kingdom (1)

Top investigators

Tony Dhillon, Bsc,FRCP, PhD (1)

Results publications

PMID 32079623